These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8927904)

  • 21. Risk stratification for the prevention of cardiovascular complications of hypertension.
    Girerd X; Giral P
    Curr Med Res Opin; 2004 Jul; 20(7):1137-42. PubMed ID: 15265258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Risk factor control in peripheral arterial disease can be improved. Registry study of secondary prophylactic drug therapy].
    Alhadad A; Wiktorsson C; Lindblad B; Gottsäter A
    Lakartidningen; 2010 Sep 29-Oct 5; 107(39):2322-5. PubMed ID: 20973248
    [No Abstract]   [Full Text] [Related]  

  • 24. [The best of epidemiology and cardiovascular prevention in 2006].
    Thomas D; Collet JP; Cottin Y; Cournot M; Ducimetière P; Ferrières J; Paillard F; Valensi P; Zeller M; Cambou JP
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():57-64. PubMed ID: 17405566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.
    Toth PP
    Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study.
    Cotter G; Cannon CP; McCabe CH; Michowitz Y; Kaluski E; Charlesworth A; Milo O; Bentley J; Blatt A; Krakover R; Zimlichman R; Reisin L; Marmor A; Lewis B; Vered Z; Caspi A; Braunwald E;
    Am Heart J; 2003 Apr; 145(4):622-7. PubMed ID: 12679757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Risk factors for arteriosclerosis].
    Henzen C
    Praxis (Bern 1994); 2001 Jan; 90(4):91-5. PubMed ID: 11213573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Heart and brain: are the risk factors the same? Are the results of primary and secondary trials comparable?].
    Castaigne A; Haziza F; Lopes-Darmon ME
    Arch Mal Coeur Vaiss; 1998 Oct; 91 Spec No 5():59-63. PubMed ID: 9833081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiplatelet drugs in cardiovascular prevention: coronary events and stroke: primary prevention.
    Prescrire Int; 2000 Jun; 9(47):89-90. PubMed ID: 11010752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Control of baseline cardiovascular risk factors in the SU-FOL-OM3 study cohort: does the localization of the arterial event matter?
    Vesin C; Galan P; Gautier B; Czernichow S; Hercberg S; Blacher J
    Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):541-8. PubMed ID: 20216318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention of cerebrovascular insults].
    Stähelin HB; Evison J; Seiler WO
    Schweiz Med Wochenschr; 1994 Nov; 124(45):1995-2004. PubMed ID: 7973532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Smoking and peripheral vascular disorders].
    Stammler F; Diehm C
    Z Arztl Fortbild (Jena); 1995 Oct; 89(5):459-66. PubMed ID: 8578773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons.
    Rehring TF; Stolcpart RS; Hollis HW;
    J Vasc Surg; 2008 May; 47(5):1108-15. PubMed ID: 18372155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cardiovascular polypill in high risk patients].
    Lafeber M; Spiering W; Bots ML; de Valk V; Visseren FL; Grobbee DE
    Ned Tijdschr Geneeskd; 2011; 155(44):A3070. PubMed ID: 22067559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hypertension and arteriosclerosis].
    Pessina AC; Pauletto P; Rossi GP; Valle R
    Ann Ital Med Int; 1992; 7(3 Suppl):112S-118S. PubMed ID: 1363625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Atherosclerosis and possibilities of dietary prevention or therapy].
    Spengel FA
    Wien Med Wochenschr Suppl; 1990; 106():suppl 13-4. PubMed ID: 2219948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive medical management of peripheral arterial disease.
    Gandhi S; Weinberg I; Margey R; Jaff MR
    Prog Cardiovasc Dis; 2011; 54(1):2-13. PubMed ID: 21722781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventive aspects in peripheral artery disease.
    Aggarwal S; Loomba RS; Arora R
    Ther Adv Cardiovasc Dis; 2012 Apr; 6(2):53-70. PubMed ID: 22337767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti-aging medicine: the evidence to the value of the antihypertensive drugs, hypoglycemic drugs and statins].
    Okumachi Y; Yokono K
    Nihon Rinsho; 2009 Jul; 67(7):1372-6. PubMed ID: 19591288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Primary nutritional and drug prevention of atherosclerosis].
    Monnier L; Avignon A; Colette C; Piperno M
    Rev Med Interne; 1999 Aug; 20 Suppl 3():360s-370s. PubMed ID: 10480187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.